首页 | 官方网站   微博 | 高级检索  
     

长春瑞滨为主的联合方案治疗晚期非小细胞肺癌45例疗效观察
引用本文:胡继德,余伦清,方献英,尚长海,冯继.长春瑞滨为主的联合方案治疗晚期非小细胞肺癌45例疗效观察[J].中国基层医药,2003,10(5):422-423.
作者姓名:胡继德  余伦清  方献英  尚长海  冯继
作者单位:464000,河南信阳市中心医院肿瘤科
摘    要:目的 观察长春瑞滨(navelbine,NVB)加顺铂(cisplatin,DDP)联合化疗治疗晚期非小细胞肺癌的疗效和不良反应。方法 45例晚期非小细胞沸癌病人接受NP(NVB DDP)方案治疗,21d为1个周期。结果 45例病人中无完全缓解者,21例部分缓解,16例稳定,8例进展,总有效率46.7%。中位生存时间9个月。主要不良反应为恶心、呕吐和骨髓抑制。结论 NVB DDP可作为治疗晚期非小细胞肺癌的一个有效安全的方案。

关 键 词:长春瑞滨  晚期  非小细胞肺癌  顺铂  化疗  联合治疗  不良反应
修稿时间:2002年12月11

Observation of the effect of the combined regimen on non-samll lung cancer(NSCLC) at advanced stage
HU Jide,YU Lunqing,FANG Xianying,et al..Observation of the effect of the combined regimen on non-samll lung cancer(NSCLC) at advanced stage[J].Chinese Journal of Primary Medicine and Pharmacy,2003,10(5):422-423.
Authors:HU Jide  YU Lunqing  FANG Xianying  
Affiliation:HU Jide,YU Lunqing,FANG Xianying,et al.Department of Tumor,Xinyang Central Hospital,Henan,464000,China
Abstract:Objective To observe the effect and side effect of navelbine(NVB) combined with cisplatin(DDP) on NSCLC at advanced stage.Methods Fourty five cases of NSCLC at advanced were treated with the regimen of NVB and DPP for 21 days.Results The total effective rate was 46.7% including partly remission in 21 cases,stabilization in 16 cases and progression in 8 cases.No patients of all 45 cases completely remissed.The median survival time was 9 months.The major side effects were nausea,vomiting and bone marrow inhibition.Conclusion The regiman of NVB and DDP may used as an effective and safe method for treating NSCLC at late stage.
Keywords:Nonsmall cell lung cancer  Chemotherapy  Navelbine  Cisplatin  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号